The Board of Directors of Hangzhou Biotest Biotech Co.,Ltd. has authorized a buyback plan on November 3, 2023.
Hangzhou Biotest Biotech Co.,Ltd.
Equities
688767
CNE1000050H0
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.65 CNY | -1.08% | -4.58% | -15.26% |
1st Jan change | Capi. | |
---|---|---|
-15.26% | 373M | |
-11.68% | 11.34B | |
+27.42% | 5.65B | |
+1.44% | 5.56B | |
-17.38% | 3.77B | |
+8.12% | 2.57B | |
-64.60% | 2.39B | |
-10.17% | 2.26B | |
+27.12% | 2.15B | |
-12.53% | 1.7B |
- Stock Market
- Equities
- 688767 Stock
- News Hangzhou Biotest Biotech Co.,Ltd.
- Hangzhou Biotest Biotech Co.,Ltd. authorizes a Buyback Plan.